June 27, 2025

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 9,737% Upside in Biotech

Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, is capturing the attention of astute investors with its ambitious potential upside of 9,737.05%. Headquartered in Vienna, Virginia, Cel-Sci..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Frontier with a 27.30% Revenue Growth

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a trailblazer in the biotechnology sector, offering innovative solutions through its platform for cell programming. Despite facing a challenging..

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating a 236% Potential Upside in a Volatile Market

Tilray Brands, Inc. (NASDAQ: TLRY), a key player in the healthcare sector, specializes in the cultivation and distribution of medical cannabis products globally. With its market..

Kamada Ltd. (KMDA) Stock Analysis: 86.71% Potential Upside Captivates Investors

Kamada Ltd. (NASDAQ: KMDA), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has been turning heads with its..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Unpacking the 288% Potential Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA) commands attention in the biotechnology sector, driven by its pioneering work in gene editing. The company is carving a niche in..

Regulus Therapeutics Inc. (RGLS) Stock Analysis: Navigating the Biotech Waves with a Unique MicroRNA Focus

Regulus Therapeutics Inc. (NASDAQ: RGLS), a specialist in biotechnology, is sailing through the dynamic waters of the healthcare sector with its innovative focus on microRNA-targeted therapies...

SIGA Technologies Inc. (SIGA): Investor Outlook with Compelling Forward P/E of 3.88

SIGA Technologies Inc. (NASDAQ: SIGA) stands as an intriguing player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 112% Potential Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is making waves in the healthcare sector with its impressive portfolio of treatments targeting rare diseases. Based out of Deer Park,..

Butterfly Network, Inc. (BFLY) Stock Analysis: Strong Buy Ratings Signal Over 100% Upside Potential

Butterfly Network, Inc. (NASDAQ: BFLY), a healthcare company operating in the medical devices industry, has captured the attention of investors with its innovative approach to ultrasound..

Prothena Corporation plc (PRTA) Stock Analysis: Unveiling a 293% Upside Potential in Biotechnology

Prothena Corporation plc (PRTA), a prominent player in the biotechnology sector, has been making waves with its innovative approach to treating diseases caused by protein dysregulation...

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a 246.77% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology sector with its focus on developing therapies for autoimmune diseases and cancer. Headquartered in Cambridge, Massachusetts,..

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a 231% Potential Upside in Biotech Innovation

For investors with an eye on the biotechnology sector, MBX Biosciences, Inc. (MBX) offers a compelling narrative marked by innovation and substantial potential upside. This clinical-stage..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Potential Upside Amidst a Volatile Market

Personalis, Inc. (NASDAQ: PSNL), a leading player in the diagnostics and research sector, is catching the attention of investors with its potential upside of 9.89%. Specializing..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring the Promising 148% Potential Upside

Arvinas, Inc. (NASDAQ: ARVN) stands as a compelling prospect in the biotechnology sector, driven by its innovative approach to targeting disease-causing proteins. As a clinical-stage company,..

COMPASS Pathways Plc (CMPS): Analyst Consensus Shows Nearly 500% Upside Potential

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm, is at the forefront of developing innovative mental health treatments. With its operations spanning the United Kingdom..

Claritev Corporation (CTEV) Stock Analysis: Navigating A -19.30% Potential Downside Amidst Healthcare Innovations

Claritev Corporation (NYSE: CTEV) stands out in the health information services sector with its innovative approach to data analytics and technology-enabled cost management. Headquartered in New..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Promising Biotech with 85.87% Upside Potential

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a clinical-stage biopharmaceutical company, offers a captivating opportunity for investors looking to tap into the burgeoning biotechnology sector. With a market..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A Promising 82.42% Upside in Neurodegenerative Therapy

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its focus on innovative treatments for neurodegenerative..

Orthofix Medical Inc. (OFIX) Stock Analysis: Unpacking a Potential 101.99% Upside

Orthofix Medical Inc. (NASDAQ: OFIX) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the medical devices industry. With a market..

Precigen, Inc. (PGEN) Stock Analysis: Unlocking a 328% Upside Potential for Investors

Investors with an eye for biotechnology opportunities may find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect. With a market cap of $422.11 million, Precigen is positioned..

Search

Funds

June 27, 2025

Search

Funds

June 27, 2025

FTSE 100

Funds